Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.46263945 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.46263945 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.19860581 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.19860581 |
5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.88919800 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.71663858 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.71124524 |
8 | complement activation, alternative pathway (GO:0006957) | 5.40680554 |
9 | sulfur amino acid catabolic process (GO:0000098) | 5.18240419 |
10 | bile acid biosynthetic process (GO:0006699) | 5.09974119 |
11 | tryptophan catabolic process (GO:0006569) | 5.05265330 |
12 | indole-containing compound catabolic process (GO:0042436) | 5.05265330 |
13 | indolalkylamine catabolic process (GO:0046218) | 5.05265330 |
14 | protein carboxylation (GO:0018214) | 5.04621521 |
15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04621521 |
16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.01007463 |
17 | regulation of triglyceride catabolic process (GO:0010896) | 5.00175919 |
18 | kynurenine metabolic process (GO:0070189) | 4.95505462 |
19 | glyoxylate metabolic process (GO:0046487) | 4.90838483 |
20 | regulation of protein activation cascade (GO:2000257) | 4.87648633 |
21 | cysteine metabolic process (GO:0006534) | 4.82911875 |
22 | negative regulation of fibrinolysis (GO:0051918) | 4.82157367 |
23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.79379731 |
24 | tryptophan metabolic process (GO:0006568) | 4.76366374 |
25 | plasma lipoprotein particle clearance (GO:0034381) | 4.68663940 |
26 | regulation of complement activation (GO:0030449) | 4.63453891 |
27 | * urea cycle (GO:0000050) | 4.62591215 |
28 | * urea metabolic process (GO:0019627) | 4.62591215 |
29 | regulation of fibrinolysis (GO:0051917) | 4.56517648 |
30 | acylglycerol homeostasis (GO:0055090) | 4.50764080 |
31 | triglyceride homeostasis (GO:0070328) | 4.50764080 |
32 | bile acid metabolic process (GO:0008206) | 4.46921680 |
33 | serine family amino acid catabolic process (GO:0009071) | 4.40011661 |
34 | amino-acid betaine metabolic process (GO:0006577) | 4.39529247 |
35 | reverse cholesterol transport (GO:0043691) | 4.33107203 |
36 | protein-lipid complex remodeling (GO:0034368) | 4.30161035 |
37 | macromolecular complex remodeling (GO:0034367) | 4.30161035 |
38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.30161035 |
39 | phospholipid efflux (GO:0033700) | 4.26421738 |
40 | lysine metabolic process (GO:0006553) | 4.26141391 |
41 | lysine catabolic process (GO:0006554) | 4.26141391 |
42 | regulation of cholesterol esterification (GO:0010872) | 4.23865605 |
43 | * nitrogen cycle metabolic process (GO:0071941) | 4.22667461 |
44 | homocysteine metabolic process (GO:0050667) | 4.22279925 |
45 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.19779765 |
46 | diacylglycerol metabolic process (GO:0046339) | 4.18860035 |
47 | positive regulation of lipid catabolic process (GO:0050996) | 4.16841083 |
48 | tyrosine metabolic process (GO:0006570) | 4.13168310 |
49 | low-density lipoprotein particle clearance (GO:0034383) | 4.12278411 |
50 | aromatic amino acid family metabolic process (GO:0009072) | 4.09292594 |
51 | alpha-amino acid catabolic process (GO:1901606) | 4.03480310 |
52 | valine metabolic process (GO:0006573) | 4.02059397 |
53 | fatty acid beta-oxidation (GO:0006635) | 3.99001771 |
54 | negative regulation of granulocyte differentiation (GO:0030853) | 3.95134241 |
55 | ethanol oxidation (GO:0006069) | 3.93084454 |
56 | fatty acid oxidation (GO:0019395) | 3.88613679 |
57 | negative regulation of cholesterol transport (GO:0032375) | 3.86970174 |
58 | negative regulation of sterol transport (GO:0032372) | 3.86970174 |
59 | acetyl-CoA metabolic process (GO:0006084) | 3.86953086 |
60 | bile acid and bile salt transport (GO:0015721) | 3.83484881 |
61 | negative regulation of lipase activity (GO:0060192) | 3.82111913 |
62 | cholesterol efflux (GO:0033344) | 3.82078003 |
63 | phospholipid homeostasis (GO:0055091) | 3.81283937 |
64 | cellular ketone body metabolic process (GO:0046950) | 3.81234169 |
65 | regulation of cholesterol storage (GO:0010885) | 3.81191366 |
66 | lipid oxidation (GO:0034440) | 3.81151050 |
67 | cellular amino acid catabolic process (GO:0009063) | 3.79439042 |
68 | fatty acid catabolic process (GO:0009062) | 3.76425997 |
69 | regulation of sequestering of triglyceride (GO:0010889) | 3.75948950 |
70 | coenzyme catabolic process (GO:0009109) | 3.75016944 |
71 | complement activation (GO:0006956) | 3.74204113 |
72 | plasma lipoprotein particle assembly (GO:0034377) | 3.67617596 |
73 | NADH metabolic process (GO:0006734) | 3.65663812 |
74 | monocarboxylic acid catabolic process (GO:0072329) | 3.65620967 |
75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.63384043 |
76 | positive regulation of fatty acid oxidation (GO:0046321) | 3.62974526 |
77 | complement activation, classical pathway (GO:0006958) | 3.62188423 |
78 | imidazole-containing compound metabolic process (GO:0052803) | 3.61329033 |
79 | glycine metabolic process (GO:0006544) | 3.59557861 |
80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59540751 |
81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59540751 |
82 | short-chain fatty acid metabolic process (GO:0046459) | 3.58650079 |
83 | fibrinolysis (GO:0042730) | 3.58533233 |
84 | cellular modified amino acid catabolic process (GO:0042219) | 3.57025569 |
85 | organic acid catabolic process (GO:0016054) | 3.56934312 |
86 | carboxylic acid catabolic process (GO:0046395) | 3.56934312 |
87 | cholesterol homeostasis (GO:0042632) | 3.56931582 |
88 | triglyceride catabolic process (GO:0019433) | 3.55349006 |
89 | neutral lipid catabolic process (GO:0046461) | 3.55116491 |
90 | acylglycerol catabolic process (GO:0046464) | 3.55116491 |
91 | cellular glucuronidation (GO:0052695) | 3.53802165 |
92 | positive regulation of cholesterol efflux (GO:0010875) | 3.53649027 |
93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53265751 |
94 | biotin metabolic process (GO:0006768) | 3.52646184 |
95 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.52634620 |
96 | regulation of cholesterol homeostasis (GO:2000188) | 3.52471002 |
97 | fatty acid transmembrane transport (GO:1902001) | 3.52011668 |
98 | sterol homeostasis (GO:0055092) | 3.51466996 |
99 | protein activation cascade (GO:0072376) | 3.51203558 |
100 | indolalkylamine metabolic process (GO:0006586) | 3.49925358 |
101 | serine family amino acid metabolic process (GO:0009069) | 3.49465860 |
102 | 2-oxoglutarate metabolic process (GO:0006103) | 3.49434832 |
103 | glutamate metabolic process (GO:0006536) | 3.47751529 |
104 | carnitine metabolic process (GO:0009437) | 3.47597489 |
105 | cytolysis (GO:0019835) | 3.47374329 |
106 | response to peptidoglycan (GO:0032494) | 3.47242509 |
107 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.45222340 |
108 | angiotensin maturation (GO:0002003) | 3.45202197 |
109 | fatty acid homeostasis (GO:0055089) | 3.44383070 |
110 | neutrophil activation involved in immune response (GO:0002283) | 3.25942777 |
111 | detection of other organism (GO:0098543) | 3.21956364 |
112 | mannose metabolic process (GO:0006013) | 3.16950634 |
113 | pinocytosis (GO:0006907) | 3.12756678 |
114 | positive regulation of cholesterol transport (GO:0032376) | 3.12347393 |
115 | positive regulation of sterol transport (GO:0032373) | 3.12347393 |
116 | lipid storage (GO:0019915) | 3.10762098 |
117 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.10760335 |
118 | detection of bacterium (GO:0016045) | 3.08765274 |
119 | regulation of sterol transport (GO:0032371) | 3.08083169 |
120 | regulation of cholesterol transport (GO:0032374) | 3.08083169 |
121 | glycosphingolipid catabolic process (GO:0046479) | 3.07835625 |
122 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07179578 |
123 | glycerolipid catabolic process (GO:0046503) | 3.06990399 |
124 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.05325676 |
125 | plasma lipoprotein particle organization (GO:0071827) | 3.04084395 |
126 | ethanol metabolic process (GO:0006067) | 2.97273838 |
127 | protein-lipid complex subunit organization (GO:0071825) | 2.95668079 |
128 | triglyceride metabolic process (GO:0006641) | 2.95248944 |
129 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.94979963 |
130 | cellular extravasation (GO:0045123) | 2.94168485 |
131 | protein-lipid complex assembly (GO:0065005) | 2.90405199 |
132 | detection of external biotic stimulus (GO:0098581) | 2.85381678 |
133 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84960754 |
134 | regulation of leukocyte degranulation (GO:0043300) | 2.83996530 |
135 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.83955455 |
136 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.83955455 |
137 | modulation by symbiont of host immune response (GO:0052553) | 2.83955455 |
138 | positive regulation by symbiont of host defense response (GO:0052509) | 2.83955455 |
139 | modulation by symbiont of host defense response (GO:0052031) | 2.83955455 |
140 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.83955455 |
141 | negative regulation of phagocytosis (GO:0050765) | 2.83695672 |
142 | regulation of mast cell degranulation (GO:0043304) | 2.83165043 |
143 | response to hydroperoxide (GO:0033194) | 2.82896890 |
144 | acylglycerol metabolic process (GO:0006639) | 2.82707563 |
145 | positive regulation of lipid storage (GO:0010884) | 2.80851349 |
146 | neutral lipid metabolic process (GO:0006638) | 2.78101538 |
147 | glycolipid catabolic process (GO:0019377) | 2.77550828 |
148 | transcytosis (GO:0045056) | 2.77481789 |
149 | oxaloacetate metabolic process (GO:0006107) | 2.74213253 |
150 | lipoprotein transport (GO:0042953) | 2.72371264 |
151 | regulation of lipoprotein particle clearance (GO:0010984) | 2.71215370 |
152 | barbed-end actin filament capping (GO:0051016) | 2.63967778 |
153 | macrophage activation involved in immune response (GO:0002281) | 2.63737570 |
154 | detection of molecule of bacterial origin (GO:0032490) | 2.63535528 |
155 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62261345 |
156 | regulation of triglyceride metabolic process (GO:0090207) | 2.61167945 |
157 | oligosaccharide catabolic process (GO:0009313) | 2.61151388 |
158 | regulation of phagocytosis (GO:0050764) | 2.59572648 |
159 | triglyceride biosynthetic process (GO:0019432) | 2.58908112 |
160 | epoxygenase P450 pathway (GO:0019373) | 2.56759083 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.43823669 |
2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.27263921 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.47142232 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89647494 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.62859067 |
6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.61874301 |
7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.21408948 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.66820079 |
9 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.57274222 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.25348583 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.16211665 |
12 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.77229306 |
13 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.39964387 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18095943 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2991115 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.93760005 |
17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88826022 |
18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88066095 |
19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79377989 |
20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75698472 |
21 | MYC_22102868_ChIP-Seq_BL_Human | 1.71318327 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.68591421 |
23 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68185770 |
24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64635704 |
25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63591903 |
26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60417885 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60208233 |
28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59476054 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53466429 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51862820 |
31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51725325 |
32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50086035 |
33 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39494632 |
34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38601060 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37727848 |
36 | MAF_26560356_Chip-Seq_TH1_Human | 1.37137163 |
37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36634641 |
38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32834048 |
39 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32373714 |
40 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29360479 |
41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29205364 |
42 | P68_20966046_ChIP-Seq_HELA_Human | 1.29099411 |
43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27098731 |
44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26817950 |
45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25565778 |
46 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24523543 |
47 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24398891 |
48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24134675 |
49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22433000 |
50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21367349 |
51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20503910 |
52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20413516 |
53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18215035 |
54 | MAF_26560356_Chip-Seq_TH2_Human | 1.17650818 |
55 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17516628 |
56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15597778 |
57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13786402 |
58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12900923 |
59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12640221 |
60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11218280 |
61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09307479 |
62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08938358 |
63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08617307 |
64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07084628 |
65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06798262 |
66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06416583 |
67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04613375 |
68 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03631676 |
69 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03185611 |
70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03073991 |
71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03043244 |
72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02489700 |
73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01803927 |
74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01762152 |
75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00598416 |
76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99055102 |
77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97789237 |
78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96842845 |
79 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96835762 |
80 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96302816 |
81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95562042 |
82 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94979241 |
83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94221716 |
84 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93495653 |
85 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93374976 |
86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92272437 |
87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92205913 |
88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91472115 |
89 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91080452 |
90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90198623 |
91 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90187518 |
92 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87328542 |
93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86860421 |
94 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86851986 |
95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86436988 |
96 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.85762169 |
97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84708364 |
98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83874213 |
99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.82161048 |
100 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.81624034 |
101 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76023341 |
102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75267338 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74713500 |
104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70926333 |
105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70875179 |
106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70150587 |
107 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69044448 |
108 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.67542722 |
109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65455503 |
110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65187512 |
111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64384203 |
112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.64233266 |
113 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.64204032 |
114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64051927 |
115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64051927 |
116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63967001 |
117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62634321 |
118 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.62422055 |
119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62391050 |
120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61785253 |
121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61619783 |
122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60691345 |
123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60379455 |
124 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60350671 |
125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59981194 |
126 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.59651638 |
127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59131330 |
128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59063759 |
129 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.58163754 |
130 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57856498 |
131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56513128 |
132 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56355240 |
133 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.56103478 |
134 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.56103478 |
135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.55533217 |
136 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.55310127 |
137 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54716930 |
138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54310419 |
139 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.53836238 |
140 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53260240 |
141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52927713 |
142 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52902751 |
143 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.52423080 |
144 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51663236 |
145 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.51577134 |
146 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.51291715 |
147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.50581573 |
148 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.50367764 |
149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.49471924 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.11084745 |
2 | MP0005360_urolithiasis | 6.45478245 |
3 | MP0005365_abnormal_bile_salt | 5.55373348 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.41885089 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.22131090 |
6 | * MP0010329_abnormal_lipoprotein_level | 3.73095207 |
7 | MP0009840_abnormal_foam_cell | 3.44160926 |
8 | MP0003191_abnormal_cellular_cholesterol | 3.42040488 |
9 | MP0003252_abnormal_bile_duct | 3.38945461 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.23335869 |
11 | MP0005670_abnormal_white_adipose | 2.75509089 |
12 | MP0005083_abnormal_biliary_tract | 2.62648320 |
13 | * MP0005332_abnormal_amino_acid | 2.36918066 |
14 | * MP0002118_abnormal_lipid_homeostasis | 2.34810253 |
15 | * MP0000609_abnormal_liver_physiology | 2.27532521 |
16 | MP0001666_abnormal_nutrient_absorption | 2.26487571 |
17 | MP0003172_abnormal_lysosome_physiology | 2.24357898 |
18 | MP0003195_calcinosis | 2.01339718 |
19 | MP0003705_abnormal_hypodermis_morpholog | 1.90255388 |
20 | MP0003828_pulmonary_edema | 1.88342623 |
21 | MP0004019_abnormal_vitamin_homeostasis | 1.86415492 |
22 | * MP0005025_abnormal_response_to | 1.77791128 |
23 | * MP0005319_abnormal_enzyme/_coenzyme | 1.73102531 |
24 | MP0001835_abnormal_antigen_presentation | 1.67688395 |
25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62532922 |
26 | MP0009785_altered_susceptibility_to | 1.56839822 |
27 | MP0001764_abnormal_homeostasis | 1.55883624 |
28 | MP0002138_abnormal_hepatobiliary_system | 1.55797701 |
29 | * MP0004130_abnormal_muscle_cell | 1.51533172 |
30 | * MP0005666_abnormal_adipose_tissue | 1.47411941 |
31 | MP0002254_reproductive_system_inflammat | 1.46972901 |
32 | MP0003186_abnormal_redox_activity | 1.43913060 |
33 | MP0002148_abnormal_hypersensitivity_rea | 1.39009965 |
34 | MP0009278_abnormal_bone_marrow | 1.36830936 |
35 | MP0000685_abnormal_immune_system | 1.36186407 |
36 | * MP0002971_abnormal_brown_adipose | 1.35798361 |
37 | MP0000858_altered_metastatic_potential | 1.35581339 |
38 | MP0003868_abnormal_feces_composition | 1.35408073 |
39 | MP0009643_abnormal_urine_homeostasis | 1.31138845 |
40 | MP0005000_abnormal_immune_tolerance | 1.30785280 |
41 | MP0008260_abnormal_autophagy | 1.30432713 |
42 | MP0003724_increased_susceptibility_to | 1.25490172 |
43 | MP0001790_abnormal_immune_system | 1.24500351 |
44 | MP0005387_immune_system_phenotype | 1.24500351 |
45 | MP0005451_abnormal_body_composition | 1.22703050 |
46 | MP0002998_abnormal_bone_remodeling | 1.21319020 |
47 | * MP0005334_abnormal_fat_pad | 1.19054352 |
48 | MP0003011_delayed_dark_adaptation | 1.18736393 |
49 | * MP0000598_abnormal_liver_morphology | 1.18375525 |
50 | MP0003690_abnormal_glial_cell | 1.17745742 |
51 | MP0002723_abnormal_immune_serum | 1.15707101 |
52 | MP0002420_abnormal_adaptive_immunity | 1.15682716 |
53 | MP0002452_abnormal_antigen_presenting | 1.15602481 |
54 | MP0008438_abnormal_cutaneous_collagen | 1.15489638 |
55 | MP0001819_abnormal_immune_cell | 1.15392994 |
56 | MP0005647_abnormal_sex_gland | 1.14519264 |
57 | MP0005058_abnormal_lysosome_morphology | 1.13912300 |
58 | MP0010155_abnormal_intestine_physiology | 1.13595480 |
59 | MP0001800_abnormal_humoral_immune | 1.13237819 |
60 | MP0000604_amyloidosis | 1.13097743 |
61 | MP0009763_increased_sensitivity_to | 1.11407548 |
62 | MP0005671_abnormal_response_to | 1.10017772 |
63 | * MP0001545_abnormal_hematopoietic_system | 1.07767010 |
64 | * MP0005397_hematopoietic_system_phenotyp | 1.07767010 |
65 | MP0002876_abnormal_thyroid_physiology | 1.07310503 |
66 | MP0003656_abnormal_erythrocyte_physiolo | 1.07203252 |
67 | MP0009764_decreased_sensitivity_to | 1.05189459 |
68 | MP0009333_abnormal_splenocyte_physiolog | 1.05110223 |
69 | MP0005535_abnormal_body_temperature | 1.04214081 |
70 | * MP0008469_abnormal_protein_level | 1.02847150 |
71 | MP0001851_eye_inflammation | 1.00643929 |
72 | MP0001661_extended_life_span | 0.99781159 |
73 | MP0009379_abnormal_foot_pigmentation | 0.99129043 |
74 | MP0003436_decreased_susceptibility_to | 0.96295250 |
75 | MP0002405_respiratory_system_inflammati | 0.95427365 |
76 | MP0000003_abnormal_adipose_tissue | 0.94453248 |
77 | MP0009697_abnormal_copulation | 0.94267656 |
78 | MP0003183_abnormal_peptide_metabolism | 0.92913222 |
79 | MP0010368_abnormal_lymphatic_system | 0.92471503 |
80 | MP0002796_impaired_skin_barrier | 0.91977536 |
81 | MP0005409_darkened_coat_color | 0.91520251 |
82 | * MP0009115_abnormal_fat_cell | 0.91495633 |
83 | * MP0005375_adipose_tissue_phenotype | 0.90989684 |
84 | * MP0002078_abnormal_glucose_homeostasis | 0.90111414 |
85 | MP0000465_gastrointestinal_hemorrhage | 0.89617539 |
86 | MP0005275_abnormal_skin_tensile | 0.88854787 |
87 | MP0005464_abnormal_platelet_physiology | 0.87207554 |
88 | * MP0009642_abnormal_blood_homeostasis | 0.86945059 |
89 | MP0002396_abnormal_hematopoietic_system | 0.85035128 |
90 | MP0005076_abnormal_cell_differentiation | 0.84715686 |
91 | MP0002132_abnormal_respiratory_system | 0.83153053 |
92 | MP0006036_abnormal_mitochondrial_physio | 0.82247950 |
93 | MP0003075_altered_response_to | 0.78079089 |
94 | * MP0002970_abnormal_white_adipose | 0.76875007 |
95 | MP0001756_abnormal_urination | 0.76626019 |
96 | * MP0004185_abnormal_adipocyte_glucose | 0.75168716 |
97 | * MP0005448_abnormal_energy_balance | 0.74124833 |
98 | MP0005376_homeostasis/metabolism_phenot | 0.73582841 |
99 | MP0006082_CNS_inflammation | 0.73151554 |
100 | MP0002060_abnormal_skin_morphology | 0.72064756 |
101 | MP0005636_abnormal_mineral_homeostasis | 0.69468415 |
102 | MP0002837_dystrophic_cardiac_calcinosis | 0.68513405 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.67265532 |
104 | MP0001853_heart_inflammation | 0.64871774 |
105 | MP0001881_abnormal_mammary_gland | 0.61948185 |
106 | MP0000249_abnormal_blood_vessel | 0.60344243 |
107 | MP0002136_abnormal_kidney_physiology | 0.60272429 |
108 | MP0003300_gastrointestinal_ulcer | 0.57562600 |
109 | MP0005164_abnormal_response_to | 0.56890442 |
110 | MP0005220_abnormal_exocrine_pancreas | 0.56632347 |
111 | MP0002419_abnormal_innate_immunity | 0.55802528 |
112 | MP0001533_abnormal_skeleton_physiology | 0.55355956 |
113 | MP0003959_abnormal_lean_body | 0.51738439 |
114 | MP0010234_abnormal_vibrissa_follicle | 0.51086894 |
115 | MP0000343_altered_response_to | 0.51000799 |
116 | MP0005166_decreased_susceptibility_to | 0.50338815 |
117 | MP0009053_abnormal_anal_canal | 0.50337231 |
118 | MP0005084_abnormal_gallbladder_morpholo | 0.50050080 |
119 | MP0004883_abnormal_blood_vessel | 0.49787511 |
120 | MP0003303_peritoneal_inflammation | 0.49476178 |
121 | MP0003638_abnormal_response/metabolism_ | 0.48941688 |
122 | * MP0001845_abnormal_inflammatory_respons | 0.48659317 |
123 | MP0005167_abnormal_blood-brain_barrier | 0.48562081 |
124 | MP0005266_abnormal_metabolism | 0.48553083 |
125 | MP0003329_amyloid_beta_deposits | 0.48111509 |
126 | MP0005408_hypopigmentation | 0.47230487 |
127 | MP0000639_abnormal_adrenal_gland | 0.46930640 |
128 | MP0002168_other_aberrant_phenotype | 0.46799285 |
129 | MP0002166_altered_tumor_susceptibility | 0.46066109 |
130 | MP0001243_abnormal_dermal_layer | 0.45977848 |
131 | * MP0003953_abnormal_hormone_level | 0.44839504 |
132 | MP0004947_skin_inflammation | 0.44639454 |
133 | MP0000579_abnormal_nail_morphology | 0.44426682 |
134 | MP0005023_abnormal_wound_healing | 0.43704845 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.52562887 |
2 | Complement deficiency (HP:0004431) | 6.29385166 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.06943711 |
4 | Intrahepatic cholestasis (HP:0001406) | 5.99287677 |
5 | Xanthomatosis (HP:0000991) | 5.88425325 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.51350171 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.39930480 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.28446218 |
9 | Hypobetalipoproteinemia (HP:0003563) | 5.15279445 |
10 | Abnormality of complement system (HP:0005339) | 4.69575574 |
11 | Hyperammonemia (HP:0001987) | 4.44051769 |
12 | Hyperglycinuria (HP:0003108) | 4.40813717 |
13 | Epidermoid cyst (HP:0200040) | 4.36346243 |
14 | Joint hemorrhage (HP:0005261) | 4.36306070 |
15 | Hypolipoproteinemia (HP:0010981) | 4.35164952 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.26339250 |
17 | Systemic lupus erythematosus (HP:0002725) | 4.21064159 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16855397 |
19 | Hyperglycinemia (HP:0002154) | 4.13793045 |
20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.12819183 |
21 | Abnormality of glycine metabolism (HP:0010895) | 4.12819183 |
22 | Ketosis (HP:0001946) | 4.10843084 |
23 | Eczematoid dermatitis (HP:0000976) | 3.99007694 |
24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.96443943 |
25 | Hypoglycemic coma (HP:0001325) | 3.94127416 |
26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.93335333 |
27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.93335333 |
28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.93335333 |
29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.87324022 |
30 | Vacuolated lymphocytes (HP:0001922) | 3.81011372 |
31 | Recurrent abscess formation (HP:0002722) | 3.72152252 |
32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.66818078 |
33 | Hypercholesterolemia (HP:0003124) | 3.58969960 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.57947978 |
35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.51231846 |
36 | Increased cerebral lipofuscin (HP:0011813) | 3.49269317 |
37 | Dysostosis multiplex (HP:0000943) | 3.48534975 |
38 | Myocardial infarction (HP:0001658) | 3.45823397 |
39 | Recurrent bacterial skin infections (HP:0005406) | 3.45807710 |
40 | Abnormality of macrophages (HP:0004311) | 3.41484555 |
41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.37664769 |
42 | Fat malabsorption (HP:0002630) | 3.37612477 |
43 | Abnormality of methionine metabolism (HP:0010901) | 3.34473862 |
44 | Glomerulonephritis (HP:0000099) | 3.30175489 |
45 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28581084 |
46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.07375025 |
47 | Ketoacidosis (HP:0001993) | 2.98549816 |
48 | Purpura (HP:0000979) | 2.98206294 |
49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.95546264 |
50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88666431 |
51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.80660691 |
52 | Skin nodule (HP:0200036) | 2.77325905 |
53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75708948 |
54 | Dicarboxylic aciduria (HP:0003215) | 2.75678386 |
55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.75678386 |
56 | Abnormality of serum amino acid levels (HP:0003112) | 2.73797254 |
57 | Amyloidosis (HP:0011034) | 2.71210233 |
58 | Hypertriglyceridemia (HP:0002155) | 2.70902901 |
59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70692259 |
60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70692259 |
61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70692259 |
62 | Hyperbilirubinemia (HP:0002904) | 2.70553230 |
63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68231547 |
64 | Mucopolysacchariduria (HP:0008155) | 2.68231547 |
65 | Delayed CNS myelination (HP:0002188) | 2.66457939 |
66 | Abnormality of purine metabolism (HP:0004352) | 2.65790290 |
67 | Colitis (HP:0002583) | 2.61263042 |
68 | Gingivitis (HP:0000230) | 2.61223689 |
69 | Hepatocellular carcinoma (HP:0001402) | 2.60500215 |
70 | Increased IgE level (HP:0003212) | 2.58582818 |
71 | Myositis (HP:0100614) | 2.57946493 |
72 | Steatorrhea (HP:0002570) | 2.54652134 |
73 | Hepatosplenomegaly (HP:0001433) | 2.54296894 |
74 | Obstructive lung disease (HP:0006536) | 2.52797113 |
75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.52797113 |
76 | Metabolic acidosis (HP:0001942) | 2.52521571 |
77 | Hemorrhage of the eye (HP:0011885) | 2.52458926 |
78 | Loss of speech (HP:0002371) | 2.49933901 |
79 | Recurrent skin infections (HP:0001581) | 2.44881872 |
80 | Polygenic inheritance (HP:0010982) | 2.44163681 |
81 | Mediastinal lymphadenopathy (HP:0100721) | 2.41756804 |
82 | Nephritis (HP:0000123) | 2.38947488 |
83 | Hydroxyprolinuria (HP:0003080) | 2.38471208 |
84 | Abnormality of proline metabolism (HP:0010907) | 2.38471208 |
85 | Increased serum ferritin (HP:0003281) | 2.36912955 |
86 | Pancreatitis (HP:0001733) | 2.34454004 |
87 | Lethargy (HP:0001254) | 2.29854698 |
88 | Spontaneous abortion (HP:0005268) | 2.29624132 |
89 | Thoracic kyphosis (HP:0002942) | 2.28794052 |
90 | Spastic diplegia (HP:0001264) | 2.27086451 |
91 | Esophageal varix (HP:0002040) | 2.25903163 |
92 | Spontaneous hematomas (HP:0007420) | 2.21092334 |
93 | Epistaxis (HP:0000421) | 2.20068446 |
94 | Sensorimotor neuropathy (HP:0007141) | 2.19651827 |
95 | Prolonged bleeding time (HP:0003010) | 2.18049356 |
96 | Vascular calcification (HP:0004934) | 2.18029195 |
97 | Vertebral compression fractures (HP:0002953) | 2.17917760 |
98 | Mitral stenosis (HP:0001718) | 2.17296092 |
99 | Orchitis (HP:0100796) | 2.17178345 |
100 | Hypoglycemic seizures (HP:0002173) | 2.14970394 |
101 | Generalized aminoaciduria (HP:0002909) | 2.13791291 |
102 | Gingival bleeding (HP:0000225) | 2.13516571 |
103 | Hypochromic microcytic anemia (HP:0004840) | 2.12481482 |
104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09462436 |
105 | Oligomenorrhea (HP:0000876) | 2.09283327 |
106 | Mutism (HP:0002300) | 2.09243598 |
107 | Gout (HP:0001997) | 2.09022547 |
108 | Meningitis (HP:0001287) | 2.08890267 |
109 | Abnormal cartilage morphology (HP:0002763) | 2.08398643 |
110 | Abnormal gallbladder morphology (HP:0012437) | 2.08103542 |
111 | Cholelithiasis (HP:0001081) | 2.07471652 |
112 | Neonatal onset (HP:0003623) | 2.07210283 |
113 | Brushfield spots (HP:0001088) | 2.06885121 |
114 | Inflammation of the large intestine (HP:0002037) | 2.06494027 |
115 | Acanthosis nigricans (HP:0000956) | 2.06172995 |
116 | Menorrhagia (HP:0000132) | 2.05681343 |
117 | Disinhibition (HP:0000734) | 2.05337006 |
118 | Cellulitis (HP:0100658) | 2.05170135 |
119 | Nausea (HP:0002018) | 2.04740120 |
120 | Gastrointestinal inflammation (HP:0004386) | 2.02311889 |
121 | Pathologic fracture (HP:0002756) | 2.01859520 |
122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01555444 |
123 | Cardiovascular calcification (HP:0011915) | 2.01399963 |
124 | Vomiting (HP:0002013) | 1.98441165 |
125 | Abnormality of the periventricular white matter (HP:0002518) | 1.98226774 |
126 | Irritability (HP:0000737) | 1.97805761 |
127 | Acanthocytosis (HP:0001927) | 1.97295562 |
128 | Recurrent fungal infections (HP:0002841) | 1.97006700 |
129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96014438 |
130 | Petechiae (HP:0000967) | 1.95046595 |
131 | Cerebral edema (HP:0002181) | 1.94296970 |
132 | Late onset (HP:0003584) | 1.93165273 |
133 | Pulmonary embolism (HP:0002204) | 1.93099429 |
134 | Malnutrition (HP:0004395) | 1.91707491 |
135 | Retinal atrophy (HP:0001105) | 1.91655985 |
136 | Thrombophlebitis (HP:0004418) | 1.90364211 |
137 | Abnormal gallbladder physiology (HP:0012438) | 1.89462379 |
138 | Cholecystitis (HP:0001082) | 1.89462379 |
139 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87977261 |
140 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87977261 |
141 | Axonal loss (HP:0003447) | 1.86020100 |
142 | Gastrointestinal infarctions (HP:0005244) | 1.85926600 |
143 | Urticaria (HP:0001025) | 1.85005432 |
144 | Abnormality of iron homeostasis (HP:0011031) | 1.83848848 |
145 | Abnormality of the lumbar spine (HP:0100712) | 1.79087941 |
146 | Opisthotonus (HP:0002179) | 1.78560651 |
147 | Thrombocytosis (HP:0001894) | 1.78443699 |
148 | Pigmentary retinal degeneration (HP:0001146) | 1.78382903 |
149 | Bone pain (HP:0002653) | 1.77959050 |
150 | Growth hormone excess (HP:0000845) | 1.77912960 |
151 | Abnormality of the thoracic spine (HP:0100711) | 1.77715658 |
152 | Upper motor neuron abnormality (HP:0002127) | 1.76733414 |
153 | Elevated hepatic transaminases (HP:0002910) | 1.76445155 |
154 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76430373 |
155 | Myoglobinuria (HP:0002913) | 1.75805587 |
156 | Hyperglycemia (HP:0003074) | 1.75475154 |
157 | Impaired platelet aggregation (HP:0003540) | 1.75003967 |
158 | Abnormal platelet function (HP:0011869) | 1.75003967 |
159 | Renal cortical cysts (HP:0000803) | 1.74543017 |
160 | Rhabdomyolysis (HP:0003201) | 1.73823886 |
161 | Polycythemia (HP:0001901) | 1.71259383 |
162 | Abnormality of the gallbladder (HP:0005264) | 1.66060401 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.68967076 |
2 | ERN1 | 4.47388435 |
3 | SIK1 | 4.38852426 |
4 | TRIB3 | 3.84729894 |
5 | RIPK4 | 3.70540490 |
6 | CAMK1D | 3.29818101 |
7 | FGFR4 | 3.28507863 |
8 | PRPF4B | 2.79620252 |
9 | TGFBR2 | 2.67239414 |
10 | PKN2 | 2.50359998 |
11 | MST1R | 2.34095792 |
12 | CAMK1G | 2.15261563 |
13 | TAOK3 | 2.13872491 |
14 | FES | 2.02288046 |
15 | INSRR | 1.98209718 |
16 | TYK2 | 1.94722128 |
17 | RIPK1 | 1.71115158 |
18 | FLT3 | 1.60794729 |
19 | MAP3K13 | 1.60314841 |
20 | SMG1 | 1.58575332 |
21 | FGFR2 | 1.55118801 |
22 | MAP2K3 | 1.49524297 |
23 | NEK9 | 1.49251811 |
24 | NME2 | 1.47881937 |
25 | MAPK15 | 1.47594315 |
26 | PTK6 | 1.44681825 |
27 | CSF1R | 1.41669002 |
28 | MAPK11 | 1.39604135 |
29 | PRKAA2 | 1.37085928 |
30 | JAK1 | 1.35802316 |
31 | TBK1 | 1.34479482 |
32 | ERBB4 | 1.33226594 |
33 | JAK2 | 1.32383182 |
34 | EPHB1 | 1.31251432 |
35 | LATS1 | 1.30919814 |
36 | PIK3CG | 1.30662934 |
37 | IRAK4 | 1.30631731 |
38 | IRAK3 | 1.29136705 |
39 | TNK2 | 1.26073748 |
40 | MAP2K4 | 1.25710458 |
41 | FRK | 1.18406050 |
42 | ABL2 | 1.12447305 |
43 | MAP3K3 | 1.09432671 |
44 | TAOK1 | 1.04575662 |
45 | FGFR3 | 1.02396478 |
46 | DAPK2 | 0.98632245 |
47 | SYK | 0.98126290 |
48 | CSK | 0.92160885 |
49 | LYN | 0.88847450 |
50 | TESK2 | 0.87606171 |
51 | MATK | 0.87072358 |
52 | CAMKK2 | 0.86774928 |
53 | KDR | 0.84954975 |
54 | TIE1 | 0.82629558 |
55 | DDR2 | 0.82561111 |
56 | MAP3K10 | 0.81914978 |
57 | TAOK2 | 0.81791734 |
58 | MAPK4 | 0.81165079 |
59 | MET | 0.80032338 |
60 | MAP3K7 | 0.78822293 |
61 | MAPK12 | 0.78051772 |
62 | CDK12 | 0.77784255 |
63 | MAP3K14 | 0.76898121 |
64 | MAP4K1 | 0.75959061 |
65 | IKBKB | 0.75202892 |
66 | MARK2 | 0.74705311 |
67 | KSR2 | 0.74599621 |
68 | PDPK1 | 0.74387837 |
69 | BLK | 0.73515635 |
70 | PDK3 | 0.73315033 |
71 | PDK4 | 0.73315033 |
72 | ZAP70 | 0.72372330 |
73 | CDC42BPA | 0.70963117 |
74 | RPS6KL1 | 0.69814641 |
75 | RPS6KC1 | 0.69814641 |
76 | MAP3K11 | 0.68100626 |
77 | GRK6 | 0.66870846 |
78 | KIT | 0.66490835 |
79 | FGR | 0.66190402 |
80 | TEC | 0.65379905 |
81 | YES1 | 0.65073683 |
82 | MAP3K6 | 0.63422467 |
83 | LCK | 0.63325908 |
84 | EPHA3 | 0.62430144 |
85 | TESK1 | 0.61536038 |
86 | RPS6KA2 | 0.60163656 |
87 | PRKAA1 | 0.60114606 |
88 | PRKACG | 0.59829628 |
89 | PDK2 | 0.59220633 |
90 | MAP2K1 | 0.58813493 |
91 | IGF1R | 0.56179699 |
92 | MOS | 0.55264675 |
93 | PRKD2 | 0.55255843 |
94 | IKBKE | 0.54915998 |
95 | IRAK2 | 0.53660584 |
96 | PRKCZ | 0.53646131 |
97 | PDK1 | 0.53113235 |
98 | HIPK2 | 0.53020654 |
99 | RET | 0.52265596 |
100 | CAMKK1 | 0.51572203 |
101 | RPS6KA6 | 0.51493078 |
102 | PDGFRA | 0.50600912 |
103 | PINK1 | 0.50415270 |
104 | MTOR | 0.49666680 |
105 | ERBB2 | 0.48515529 |
106 | GRK7 | 0.48082522 |
107 | SCYL2 | 0.48016675 |
108 | PIM2 | 0.46270361 |
109 | LRRK2 | 0.46120218 |
110 | CAMK1 | 0.45075091 |
111 | BMX | 0.44030668 |
112 | JAK3 | 0.43148704 |
113 | PRKG2 | 0.41097345 |
114 | SGK3 | 0.40931159 |
115 | CDK9 | 0.39192635 |
116 | MAPKAPK3 | 0.38564834 |
117 | PAK4 | 0.38292313 |
118 | EPHB2 | 0.36475601 |
119 | STK3 | 0.36085472 |
120 | DYRK1B | 0.35987927 |
121 | ABL1 | 0.35060914 |
122 | BTK | 0.34908490 |
123 | PAK2 | 0.34605793 |
124 | MAPK7 | 0.34596514 |
125 | ITK | 0.34393954 |
126 | PTK2 | 0.34143125 |
127 | ICK | 0.34113768 |
128 | EEF2K | 0.33176704 |
129 | EGFR | 0.33138313 |
130 | MAP2K2 | 0.31952663 |
131 | * GSK3A | 0.30201701 |
132 | MAP2K6 | 0.29839214 |
133 | MAP3K2 | 0.29762212 |
134 | HCK | 0.29415563 |
135 | PRKD1 | 0.28678048 |
136 | MAP3K1 | 0.28591475 |
137 | PIK3CA | 0.28431712 |
138 | CAMK4 | 0.27588972 |
139 | STK10 | 0.26976806 |
140 | IRAK1 | 0.26410237 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.12399877 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53247405 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04078183 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79837340 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78765232 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75232432 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74131627 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72053499 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62039271 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51481392 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50110314 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.46876188 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.44154140 |
14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.31546863 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27368509 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.22256062 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16960660 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.10742269 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02597844 |
20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93011045 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91751670 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88832727 |
23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78330303 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76810581 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71679816 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71428752 |
27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62431578 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59758416 |
29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57869356 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55057192 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52545474 |
32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50071399 |
33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48381656 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40900453 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39124554 |
36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35904733 |
37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35597641 |
38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32750296 |
39 | Bile secretion_Homo sapiens_hsa04976 | 1.30938579 |
40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28778290 |
41 | ABC transporters_Homo sapiens_hsa02010 | 1.28263809 |
42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28075791 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26380683 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.25657377 |
45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19593392 |
46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14607644 |
47 | Tuberculosis_Homo sapiens_hsa05152 | 1.13240533 |
48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10045229 |
49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10022230 |
50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04807343 |
51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00502731 |
52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99702381 |
53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96031397 |
54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95979906 |
55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95009090 |
56 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91034545 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90675708 |
58 | Asthma_Homo sapiens_hsa05310 | 0.90473546 |
59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89562589 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89405855 |
61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84625175 |
62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83788600 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 0.81846665 |
64 | Phagosome_Homo sapiens_hsa04145 | 0.81465770 |
65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80083118 |
66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74521969 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73598550 |
68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73514342 |
69 | Allograft rejection_Homo sapiens_hsa05330 | 0.73226456 |
70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72744245 |
71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72378476 |
72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72157015 |
73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69498466 |
74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69329276 |
75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65674168 |
76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65560788 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64030787 |
78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60790114 |
79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59514176 |
80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59446652 |
81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58619729 |
82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58584421 |
83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51420777 |
84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50955644 |
85 | Insulin resistance_Homo sapiens_hsa04931 | 0.50649463 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.50384662 |
87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50086913 |
88 | Influenza A_Homo sapiens_hsa05164 | 0.49478886 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.46535106 |
90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41433052 |
91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41027297 |
92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39497723 |
93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39267770 |
94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38564142 |
95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38377214 |
96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38247235 |
97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36638187 |
98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36489228 |
99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36357598 |
100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35800275 |
101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35580737 |
102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34898476 |
103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31556818 |
104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27207349 |
105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26919656 |
106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25688247 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.18937554 |
108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18536192 |
109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16727646 |
110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.13385413 |
111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12577471 |
112 | Pertussis_Homo sapiens_hsa05133 | 0.08135428 |
113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.03918909 |
114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1325109 |
115 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.1234795 |
116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1216446 |
117 | Malaria_Homo sapiens_hsa05144 | -0.1212671 |
118 | Legionellosis_Homo sapiens_hsa05134 | -0.1155379 |
119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0945183 |
120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0911022 |
121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0879911 |
122 | Hepatitis C_Homo sapiens_hsa05160 | -0.0703769 |
123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0602198 |
124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0598290 |
125 | Amoebiasis_Homo sapiens_hsa05146 | -0.0534679 |
126 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0207029 |
127 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0123353 |
128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0046218 |